Exelixis
EXEL
#1789
Rank
C$13.59 B
Marketcap
$47.61
Share price
0.21%
Change (1 day)
62.18%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $70.99 CAD on 2000-07-26

Lowest end of day price: $1.86 CAD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$51.06 1.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
$78.32 4.19%๐Ÿ‡ซ๐Ÿ‡ท France
$142.52 0.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$85.16 0.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$410.69 1.15%๐Ÿ‡บ๐Ÿ‡ธ USA
$221.36 1.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$38.86 1.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.71 1.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.62 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA